Cited by 22Circadian rhythm and melatoninCardiovascular Health and Disease PreventionNitric Oxide and Endothelin Effects

Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial

Open access
Hoseini, Shervin Ghaffari, Heshmat‐Ghahdarijani, Kiyan, Khosrawi, Saeid, Garakyaraghi, Mohammad, Shafie, Davood, Roohafza, Hamidreza, Mansourian, Marjan, Azizi, Elham +2 more·2021·Clinical Cardiology

Abstract

BACKGROUND: This study aimed to investigate the effect of melatonin supplementation on endothelial function in patients with heart failure with reduced ejection fraction (HFrEF). METHODS: This is an analysis of the MeHR trial, a randomized double-blinded placebo-controlled clinical trial with two parallel arms of 1:1. Oral 10 mg melatonin tablets or placebo was administered for 24 weeks. Deference in the percentage of flow-mediated dilatation (FMD) after the intervention was the primary outcome. RESULTS: Ninety-two patients were included in the study (age: 62.7±10.3 years, 87.0% male, ejection fraction (EF): 28.6±8.1). After adjustment for baseline FMD and age, a statistically significant difference in post-treatment FMD in favor of the melatonin group was seen (estimated marginal means [95%CI], melatonin: 7.84% [6.69-8.98], placebo: 5.98% [4.84-7.12], p = .027). There was no significant difference in the mean of post-treatment systolic/diastolic blood pressure, serum total antioxidant capacity, and serum malondialdehyde (MDA) between groups. Subgroup analysis showed significant improvement in FMD and MDA in the melatonin group in nondiabetic patients, while no difference was seen between study groups in diabetic patients. CONCLUSIONS: Melatonin supplementation in HFrEF might improve endothelial function; however, this beneficial effect might not be seen in diabetic patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/clc.23682

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Oral 10 mg melatonin daily for twenty-four weeks improved endothelial function in heart failure with reduced ejection fraction patients who did not also have diabetes.

    “A randomized double-blinded placebo-controlled clinical trial with two parallel arms using either placebo or oral 10 mg melatonin supplementation per day for twenty-four weeks in patients with heart failure and reduced ejection fraction observed improvements in endothelial function in those who did not also have diabetes [125].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoseini, S. G., Heshmat‐Ghahdarijani, K., Khosrawi, S., Garakyaraghi, M., Shafie, D., Roohafza, H., Mansourian, M., Azizi, E., Gheisari, Y., & Sadeghi, M.
Affiliations
Isfahan University of Medical Sciences (IR)
Corresponding author
Sadeghi, Masoumeh
Venue
Clinical Cardiology
Publisher
Wiley
Published
2021-06-28
Volume
44
Issue
9
Pages
1263-1271
ISSN
  • 0160-9289 (ISSN-L)
  • 1932-8737
OpenAlex
W3173221931
Cited by
22
References
31
Citations by year
2026: 4 · 2025: 7 · 2024: 6 · 2023: 2 · 2022: 2 · 2021: 1
FWCI
1.45
Type
journal article
Language
en
Open access
Locations
  • Clinical Cardiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institute for Medical Research Development (397180)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
Keywords
melatonin supplementation, endothelial function, heart failure with reduced ejection fraction, flow-mediated dilation, oxidative stress, malondialdehyde, diabetes mellitus, antioxidant capacity
MeSH terms
Double-Blind Method, Female, Heart Failure, Humans, Male, Melatonin, Middle Aged, Stroke Volume, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review